Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieselot van Erven

Showing results (1-10 of 120) with videos related to

Pageof 12
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 29, 2010
Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA surveyGermanas Marinskis, Lieselot van Erven,
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 5, 2009
Validation of success following atrial fibrillation ablation: a European surveyFranck Halimi, Lieselot Van Erven,
Heart (British Cardiac Society)|April 16, 2008
Troubleshooting implantable cardioverter-defibrillator related problemsLieselot van Erven, Martin J Schalij
Heart (British Cardiac Society)|September 15, 2010
Amiodarone: an effective antiarrhythmic drug with unusual side effectsLieselot van Erven, Martin J Schalij
Pacing and Clinical Electrophysiology : PACE|February 8, 2012
Unrecognized failure of a narrow caliber defibrillation lead: the role of defibrillation threshold testing in identifying an unprotected individualDarryl P Leong, Lieselot van Erven
Heart Rhythm|March 8, 2007
Anger and arrhythmiasMartin J Schalij, Lieselot van Erven
Heart Rhythm|March 28, 2017
The right timing for the left lead: Now or later?Dilek Yilmaz, Lieselot van Erven, C Jan Willem Borleffs, et al.
European Journal of Cardiovascular Nursing|January 22, 2022
Implantable cardioverter-defibrillators and the older patient: the Dutch clinical practiceDilek Yilmaz, Anastasia D Egorova, Martin J Schalij, et al.
European Heart Journal. Case Reports|June 14, 2021
Failing systemic right ventricle in a patient with dextrocardia and complex congenitally corrected transposition of the great arteries: a case report of successful transvenous cardiac resynchronization therapyMarieke Nederend, Lieselot van Erven, Katja Zeppenfeld, et al.
European Heart Journal. Case Reports|October 21, 2021
Fusion cardiac resynchronization therapy in an left ventricular assist device patient from two devices and crossing leads: a case reportAnastasia D Egorova, Lieselot van Erven, Saskia L M A Beeres, et al.
Pageof 12

Showing results (1-10 of 120) with videos related to

Sort By:
Pageof 12
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 29, 2010
Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA surveyGermanas Marinskis, Lieselot van Erven,
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 5, 2009
Validation of success following atrial fibrillation ablation: a European surveyFranck Halimi, Lieselot Van Erven,
Heart (British Cardiac Society)|April 16, 2008
Troubleshooting implantable cardioverter-defibrillator related problemsLieselot van Erven, Martin J Schalij
Heart (British Cardiac Society)|September 15, 2010
Amiodarone: an effective antiarrhythmic drug with unusual side effectsLieselot van Erven, Martin J Schalij
Pacing and Clinical Electrophysiology : PACE|February 8, 2012
Unrecognized failure of a narrow caliber defibrillation lead: the role of defibrillation threshold testing in identifying an unprotected individualDarryl P Leong, Lieselot van Erven
Heart Rhythm|March 8, 2007
Anger and arrhythmiasMartin J Schalij, Lieselot van Erven
Heart Rhythm|March 28, 2017
The right timing for the left lead: Now or later?Dilek Yilmaz, Lieselot van Erven, C Jan Willem Borleffs, et al.
European Journal of Cardiovascular Nursing|January 22, 2022
Implantable cardioverter-defibrillators and the older patient: the Dutch clinical practiceDilek Yilmaz, Anastasia D Egorova, Martin J Schalij, et al.
European Heart Journal. Case Reports|June 14, 2021
Failing systemic right ventricle in a patient with dextrocardia and complex congenitally corrected transposition of the great arteries: a case report of successful transvenous cardiac resynchronization therapyMarieke Nederend, Lieselot van Erven, Katja Zeppenfeld, et al.
European Heart Journal. Case Reports|October 21, 2021
Fusion cardiac resynchronization therapy in an left ventricular assist device patient from two devices and crossing leads: a case reportAnastasia D Egorova, Lieselot van Erven, Saskia L M A Beeres, et al.
Pageof 12